Stock Market News1 week UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study Zacks
UNITY Biotechnology stock loses 29% as the mid-stage DME study of the lead candidate, UBX1325, fails to achieve statistical significance for the primary goal.
X4 hours Is Regeneron Pharmaceuticals, Inc. (REGN) The Most Profitable Biotech Stock To Buy Right Now? Yahoo Finance
X3 days Regeneron Pharmaceuticals, Inc. (REGN): Among Blue Chip Stocks to Invest in at 52-Week Lows Yahoo Finance
X3 weeks Market Update: MDU, REGN, DG, BHF Yahoo Finance
X3 weeks Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners 2025 Global Healthcare Conference Call Transcript Seeking Alpha
X3 weeks The Nasdaq is Cratering But REGN, BIIB and CSGP Are Up Big Today 24/7 Wall St.
X4 weeks Why Is Regeneron (REGN) Down 4.1% Since Last Earnings Report? Zacks
X4 weeks Regeneron Pharmaceuticals, Inc. (REGN) TD Cowen 45th Annual Health Care Conference (Transcript) Seeking Alpha
X4 weeks Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug Zacks
X1 month SNY and REGN’s Dupixent sBLA for Skin Disease Gets FDA’s Priority Tag Zacks
X2 months Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval Zacks
X2 months Company News for Feb 5, 2025 Zacks
X2 months Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend Zacks
X2 months Regeneron Pharmaceuticals, Inc. (REGN) Q4 2024 Earnings Call Transcript Seeking Alpha
X2 months Compared to Estimates, Regeneron (REGN) Q4 Earnings: A Look at Key Metrics Zacks
X2 months Regeneron (REGN) Q4 Earnings and Revenues Beat Estimates Zacks
X2 months Regeneron to Report Q4 Earnings: Is a Beat in the Cards? Zacks
X2 months Ahead of Regeneron (REGN) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics Zacks
X2 months Earnings Preview: Regeneron (REGN) Q4 Earnings Expected to Decline Zacks
X3 months Regeneron Reports Eylea Sales, Provides Other Pipeline Updates Zacks
X3 months Regeneron Pharmaceuticals, Inc. (REGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript) Seeking Alpha
X3 months Regeneron Stock Plunges 35.6% in Six Months: Fold or Hold? Zacks
X3 months Why Regeneron (REGN) is Poised to Beat Earnings Estimates Again Zacks
X4 months REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks
X4 months Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks
X4 months Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks
XThe Stock Market News
The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.